Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
28 February 2025 - 12:52PM
Edgar (US Regulatory)
The following table sets forth all transactions in the Common Shares effected by the Reporting Persons since the filing of Amendment No. 6 on February 14, 2025 through February 26, 2025. All such transactions were effected in the open market
through a broker.
|
Reporting Person
|
Title of Security
|
Date of Transaction
|
Nature of Transaction
|
Quantity
|
Price
|
|
GEM II
|
Common Shares
|
02/20/2025
|
Sell
|
3,218
|
|
$26.2789(1)
|
|
GEM II
|
Common Shares
|
02/21/2025
|
Sell
|
9,751
|
|
$25.7609(2)
|
|
GEM II
|
Common Shares
|
02/24/2025
|
Sell
|
72,145
|
|
$25.7523(3)
|
|
GEM II
|
Common Shares
|
02/25/2025
|
Sell
|
196,066
|
|
$25.8013(4)
|
|
GEM II
|
Common Shares
|
02/26/2025
|
Sell
|
309,367
|
|
$25.8131(5)
|
(1) This transaction was executed in multiple trades at prices ranging from $26.20 to $26.51, inclusive. The price reported above reflects the weighted average sale price. The Reporting Persons undertake to provide to the Issuer, any security holder
of the Issuer, or the staff of the SEC, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth herein.
(2) This transaction was executed in multiple trades at prices ranging from $25.75 to $25.769, inclusive. The price reported above reflects the weighted average sale price. The Reporting Persons undertake to provide to the Issuer, any security
holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth herein.
(3) This transaction was executed in multiple trades at prices ranging from $25.75 to $25.758, inclusive. The price reported above reflects the weighted average sale price. The Reporting Persons undertake to provide to the Issuer, any security
holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth herein.
(4) This transaction was executed in multiple trades at prices ranging from $25.75 to $26.005, inclusive. The price reported above reflects the weighted average sale price. The Reporting Persons undertake to provide to the Issuer, any security
holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth herein.
(5) This transaction was executed in multiple trades at prices ranging from $25.75 to $26.25, inclusive. The price reported above reflects the weighted average sale price. The Reporting Persons undertake to provide to the Issuer, any security
holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth herein.
IBEX (NASDAQ:IBEX)
Historical Stock Chart
From Feb 2025 to Mar 2025
IBEX (NASDAQ:IBEX)
Historical Stock Chart
From Mar 2024 to Mar 2025
